<DOC>
	<DOCNO>NCT03106623</DOCNO>
	<brief_summary>The objective study evaluate efficacy safety ONO-8577 compare combination solifenacin succinate mirabegron placebo overactive bladder</brief_summary>
	<brief_title>Study ONO-8577 Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>Solifenacin Succinate</mesh_term>
	<mesh_term>Mirabegron</mesh_term>
	<criteria>Patient symptom overactive bladder â‰¥6 month Patient genuine stress incontinence , stresspredominant mixed urinary incontinence Patient never experience urge urinary incontinence disease duration overactive bladder</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>